Tetrakis(dipyridin-2-ylazanide);tetraphenylboranuide;tungsten;tungsten(2+)
C64H52BN12W2-3 — CID 139127430
Data last refreshed: (MolForge compound catalog, from PubChem)
About Tetrakis(dipyridin-2-ylazanide);tetraphenylboranuide;tungsten;tungsten(2+)
Tetrakis(dipyridin-2-ylazanide);tetraphenylboranuide;tungsten;tungsten(2+) (PubChem CID 139127430) has the molecular formula C64H52BN12W2-3 and a molecular weight of 1367.70 g/mol. Its IUPAC name is tetrakis(dipyridin-2-ylazanide);tetraphenylboranuide;tungsten;tungsten(2+).
Molecular Properties
| Compound Name | Tetrakis(dipyridin-2-ylazanide);tetraphenylboranuide;tungsten;tungsten(2+) |
|---|---|
| PubChem CID | 139127430 |
| Molecular Formula | C64H52BN12W2-3 |
| Molecular Weight | 1367.70 g/mol |
| Exact Mass | 1367.36 |
| IUPAC Name | tetrakis(dipyridin-2-ylazanide);tetraphenylboranuide;tungsten;tungsten(2+) |
| SMILES | [W+2].[W].c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1.c1ccc([N-]c2ccccn2)nc1.c1ccc([N-]c2ccccn2)nc1.c1ccc([N-]c2ccccn2)nc1.c1ccc([N-]c2ccccn2)nc1 |
| InChI | InChI=1S/C24H20B.4C10H8N3.2W/c1-5-13-21(14-6-1)25(22-15-7-2-8-16-22,23-17-9-3-10-18-23)24-19-11-4-12-20-24;4*1-3-7-11-9(5-1)13-10-6-2-4-8-12-10;;/h1-20H;4*1-8H;;/q5*-1;;+2 |
| InChIKey | XYIZGNVEXYYZLK-UHFFFAOYSA-N |
| XLogP | 14.31 |
| TPSA | 159.52 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 79 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1367.70 |
| LogP ≤ 5 | 14.31 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'heavy_metal', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139127430 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.